CT-Scans

I've written before about the dangers of transparency and medical technology, at least when it comes to diagnosing back pain. Simply put, doctors tend to assume that any imaging technology with better resolution will lead to better diagnoses. But that's often not the case:

A large study published in the Journal of the American Medical Association (JAMA) randomly assigned 380 patients with back pain to undergo two different types of diagnostic analysis. One group received X-rays. The other group got diagnosed using MRI's, which give the doctor a much more detailed picture of the underlying anatomy.

Which group fared better? Did better pictures lead to better treatments? There was no difference in patient outcome: the vast majority of people in both groups got better. More information didn't lead to less pain. But stark differences emerged when the study looked at how the different groups were treated. Nearly 50 percent of MRI patients were diagnosed with some sort of disc abnormality, and this diagnosis led to intensive medical interventions. The MRI group had more doctor visits, more injections, more physical therapy and were more than twice as likely to undergo surgery. Although these additional treatments were very expensive, they had no measurable benefit.

Yesterday, the Times had a fascinating story on heart CT-scans which, like MRI, allow doctors to see all sorts of new stuff. They can detect the buildup of plaque in arteries and locate abnormalities in heart muscle. Unfortunately, the medical benefits of CT-scans have yet to be proven (arterial plaque, like spinal disc abnormalities, can also be a normal consequence of the aging process), the technology is extremely expensive and each scan subjects patients to large doses of radiation, or the equivalent of several hundred x-rays. Nevertheless, the CT-scans continue to increase in popularity:

Increasing use of the scans, formally known as CT angiograms, is part of a much larger trend in American medicine. A faith in innovation, often driven by financial incentives, encourages American doctors and hospitals to adopt new technologies even without proof that they work better than older techniques. Patient advocacy groups and some doctors are clamoring for such evidence. But the story of the CT angiogram is a sobering reminder of the forces that overwhelm such efforts, making it very difficult to rein in a new technology long enough to determine whether its benefits are worth its costs.

Some medical experts say the American devotion to the newest, most expensive technology is an important reason that the United States spends much more on health care than other industrialized nations -- more than $2.2 trillion in 2007, an estimated $7,500 a person, about twice the average in other countries -- without providing better care.

More like this

Over at the wonderful World's Fair, Ben Cohen has an interview with Kelly Joyce, author of the forthcoming Magnetic Appeal: MRI and the Myth of Transparency. Here is how Joyce summarizes the main argument of her book: In the United States, MRI is socially constructed as a sacred technology--one…
David Leonhardt makes a good point. Controlling health care costs - one of our most important domestic policy problems - will require our politicians to make hard (and unpopular) decisions. In Idaho Falls, Idaho, anyone suffering from the sort of lower back pain that may conceivably be helped by…
One of the case studies I use in How We Decide when discussing the dangers of information overload concerns the diagnosis of back pain. Before the introduction of MRI's in the late 1980s, doctors were forced to rely on X-rays when diagnosing back pain. X-rays provide doctors with a limited amount…
Over at Mind Matters, Chadrick Lane reviews a fascinating experiment that revealed the rewarding properties of information, regardless of whether or not the information actually led to more rewards: In the experimental design, monkeys were placed in front of a computer screen and were trained to…

In addition to American healthcare using the newest equipment, we also test a lot more than most countries do. Some of this is rooted in the incentives of the tort system, since if you don't test and something is wrong, you can get sued for it even if the probability of it being a problem is small (same for not intervening for an issue found in a test that is unlikely to be serious), the rest is probably a product culture and intransparent pricing (it normally doesn't cost an insured patient significantly more to have a test).